37
Mortality from ALZHEIMER’S DISEASE Among Arizona Residents 2000-2017
Mortality from ALZHEIMER’S DISEASE
Among Arizona Residents
2000-2017
~ Health and Wellness for all Arizonans ~
Douglas A. Ducey, Governor State of Arizona
Cara M. Christ, M.D., M.S., Director Arizona Department of Health Services
ARIZONA DEPARTMENT OF HEALTH SERVICES BUREAU OF PUBLIC HEALTH STATISTICS
POPULATION HEALTH AND VITAL STATISTICS SECTION 150 North 18th Avenue, Suite 550
Phoenix, Arizona 85007 Phone: 602-542-7333; FAX: 602-542-2940
http://pub.azdhs.gov/health-stats
This publication can be made available in alternative format. Please contact the Bureau of Public Health Statistics
at 602-542-7333 (voice) or call 1-800-367-8939 (TDD).
The Arizona Department of Health Services is an Equal Employment Opportunity Agency.
Permission to quote from or reproduce materials from this publication is granted when due acknowledgment is made.
MORTALITY FROM ALZHEIMER’S DISEASE AMONG ARIZONA RESIDENTS,
2000-2017
by
Marguerite L. S. Kemp, Ph.D., Arizona Vital Statistician, Yan Huang, M.S., Vital Statistics Health Management Analyst
Clare Torres, Senior Health Data Analyst
May 2019
ACKNOWLEDGEMENTS
Our appreciation to S. Robert Bailey, Bureau Chief, for reviewing the typescript.
MORTALITY FROM ALZHEIMER’S DISEASE AMONGARIZONA RESIDENTS, 2000-2017
Table of Contents
PURPOSE .............................................................................................................................................................. 1 METHODS AND SOURCES ...................................................................................................................................... 1 KEY FINDINGS ..................................................................................................................................................... 3 DATA TABLES ..................................................................................................................................................... 11
List of Figures
Figure 1 ................................................................................................................................................................ 3 ALZHEIMER’S DISEASE AMONG THE LEADING CAUSES OF DEATH, ARIZONA, 2017
Figure 2 ................................................................................................................................................................ 3 TRENDS IN AGE-ADJUSTED MORTALITY RATES FOR ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH BY YEAR, ARIZONA, 2000-2017
Figure 3 ................................................................................................................................................................ 4 AGE-ADJUSTED MORTALITY RATES FOR ALZHEIMER’S DISEASE BY GENDER AND YEAR, ARIZONA, 2000-2017
Figure 4 ................................................................................................................................................................ 4 AGE-ADJUSTED MORTALITY RATES FOR ALZHEIMER’S DISEASE BY GENDER AND RACE/ETHNIC GROUP, ARIZONA, 2017
Figure 5 ................................................................................................................................................................ 5 AGE-SPECIFIC MORTALITY RATES FOR ALZHEIMER’S DISEASE AMONG ARIZONANS AGED 55 YEARS AND OLDER, 2017
Figure 6 ................................................................................................................................................................ 5 MORTALITY AND MORTALITY RATES FOR ALZHEIMER’S DISEASE AMONG ARIZONA ELDERLY RESIDENTS 65 YEARS AND OLDER, 2007--2017
Figure 7 ................................................................................................................................................................ 6 MORTALITY RATES FOR ALZHEIMER’S DISEASE BY GENDER AND YEAR AMONG ARIZONA ELDERLY RESIDENTS 65 YEARS AND OLDER, 2000-2017
Figure 8 ................................................................................................................................................................ 6 MORTALITY RATES FOR ALZHEIMER’S DISEASE BY GENDER AND YEAR AMONG ARIZONANS 75-84 YEARS OLD, 2007-2017
Figure 9 ................................................................................................................................................................ 7 MORTALITY RATES FOR ALZHEIMER’S DISEASE BY GENDER AND YEAR AMONG ARIZONANS 85 YEARS OLD AND OLDER, 2007-2017
Figure 10 .............................................................................................................................................................. 7 AVERAGE AGE AT DEATH FOR SELECTED LEADING CAUSES OF DEATH, ARIZONA, 2017
Figure 11 .............................................................................................................................................................. 8 PERCENT OF ELDERLY 65+ BY RACE/ETHNICITY AND PROPORTIONAL CONTRIBUTION TO MORTALITY FROM ALZHEIMER’S DISEASE, ARIZONA, 2017
Figure 12 .............................................................................................................................................................. 8 AGE-ADJUSTED MORTALITY RATES FOR ALZHEIMER’S DISEASE BY GENDER IN URBAN AND RURAL AREAS ARIZONA, 2017
Figure 13 ............................................................................................................................................................. 9 AGE-ADJUSTED MORTALITY RATES FOR ALZHEIMER’S DISEASE BY COUNTY OF RESIDENCE ARIZONA, 2017
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
List of Tables
Table 1 ............................................................................................................................................................... 13 NUMBER OF DEATHS FROM ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF MORTALITY BY YEAR, ARIZONA, 2000-2017
Table 2 ............................................................................................................................................................... 14 AGE-ADJUSTED MORTALITY RATES FOR ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH, ARIZONA, 2000-2017
Table 3 ............................................................................................................................................................... 15 AGE-ADJUSTED MORTALITY RATES FOR ALZHEIMER’S DISEASE BY GENDER AND YEAR, ARIZONA, 2000-2017
Table 4 ............................................................................................................................................................... 15 NUMBER OF DEATHS FROM ALZHEIMER’S DISEASE BY GENDER AND YEAR, ARIZONA, 2000-2017
Table 5 ............................................................................................................................................................... 16 NUMBER OF DEATHS FROM ALZHEIMER’S DISEASE BY RACE/ETHNICITY AND GENDER, ARIZONA, 2000-2017
Table 6 ............................................................................................................................................................... 17 NUMBER OF DEATHS FROM ALZHEIMER’S DISEASE BY URBAN/RURAL AREA AND GENDER, ARIZONA, 2000, 2007, 2010, AND 2017
Table 7 ............................................................................................................................................................... 18 NUMBER OF DEATHS FROM ALZHEIMER’S DISEASE BY COUNTY OF RESIDENCE AND YEAR, ARIZONA, 2000-2017
Table 8 ............................................................................................................................................................... 19 NUMBER OF DEATHS FROM ALZHEIMER’S DISEASE BY AGE GROUP AND GENDER, ARIZONA, 2000, 2007, 2010, AND 2017
Table 9 ............................................................................................................................................................... 20 ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH AMONG ELDERLY 65 YEARS AND OLDER, BY YEAR, ARIZONA, 2000-2017
Table 10 ............................................................................................................................................................. 21 ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH AMONG ELDERLY MALES 65 YEARS AND OLDER, BY YEAR, ARIZONA, 2000-2017
Table 11 ............................................................................................................................................................. 21 ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH AMONG ELDERLY FEMALES 65 YEARS AND OLDER, BY YEAR, ARIZONA, 2000-2017
Table 12 ............................................................................................................................................................. 22 ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH AMONG ELDERLY 65 YEARS AND OLDER, BY GENDER, AREA, AND RACE/ETHNICITY, ARIZONA, 2017
Table 13 ............................................................................................................................................................. 23 ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH AMONG ELDERLY 65-74 YEARS OLD, BY GENDER, AREA, AND RACE/ETHNICITY, ARIZONA, 2017
Table 14 ............................................................................................................................................................. 24 ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH AMONG ELDERLY 75-84 YEARS OLD, BY GENDER, AREA AND RACE/ETHNICITY, ARIZONA, 2017
Table 15 ............................................................................................................................................................. 25 ALZHEIMER’S DISEASE AND OTHER LEADING CAUSES OF DEATH AMONG ELDERLY 85 YEARS AND OLDER, BY GENDER, AREA, AND RACE/ETHNICITY, ARIZONA, 2017
Table 16 ............................................................................................................................................................. 26 POPULATION AT RISK: ELDERLY 65 YEARS AND OLDER, BY GENDER, AGE GROUP, AND RACE/ETHNICITY, ARIZONA, 2000, 2010, AND 2017
Table 17 ............................................................................................................................................................. 28 POPULATION AT RISK: ELDERLY 65 YEARS AND OLDER, BY GENDER, AGE GROUP, AND COUNTY OF RESIDENCE, ARIZONA, 2000, 2010, AND 2017
ii MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
PURPOSE In 2000, Alzheimer’s disease was the 7th leading cause of death for all ages, a ranking that changed since then, as the disease was 5th leading cause of death in 2017. Alzheimer’s disease is a progressive degenerative and increasingly debilitating condition characterized by progressive loss of memory, difficulty in finding right words or understanding what people are saying, difficulty in performing previously routine tasks, and changes in personality. Alzheimer’s disease gradually destroys vital nerve cells in the brain. At later stages of the disease, persons with Alzheimer’s disease are bedridden and susceptible to developing other medical conditions, especially pneumonia. These secondary conditions may also result in death. The purpose of this report is to provide information to individuals interested in Alzheimer’s disease mortality among Arizona residents. The data for 2017 are placed in a temporal context by comparison with the data for the preceding years. METHODS AND SOURCES Data on the number and characteristics of Alzheimer’s deaths were obtained from the death certificates filed with the Arizona Department of Health Services. Population denominators for Arizona residents, used to calculate rates, are the latest available estimates by the Arizona Office of Economic Opportunity and census enumerations from the U.S. Census Bureau (www.census.gov/). Beginning with the 2000 data year, two major changes have occurred in Arizona, affecting the computation of mortality rates, tabulation of leading causes of death and analyses of mortality data over time. First, a new revision of the International Classification of Diseases (ICD), used to classify causes of death, was implemented. The Tenth Revision (ICD-10) has replaced the Ninth Revision (ICD-9), which was in effect since 1979. Second, a new population standard for the age adjustment of mortality rates has replaced the standard based on the 1940 population and used since 1943. Both changes have profound effects on the comparability of mortality data and continuity in statistical trends. Age-adjusted rates can only be compared to other age-adjusted rates that use the same population standard. Breaks in comparability of mortality statistics effective with deaths occurring in 2000 also result from the implementation of ICD-10. Any comparison of causes of mortality in Arizona from the 2000-2017 period and prior years needs to take into account the changes in statistical trends that can be attributed to changes in the classification system alone.
This report includes tables where small cells and related totals are suppressed. Using suppression rules similar to those used by the National Center for Health Statistics (NCHS), this report now attempts to maintain the anonymity of the individuals whose vital records are summarized herein. In cell suppression, the first task is primary suppression, or removing non-zero counts in the body of a table that fall below a certain number. Primary cells that were less than six but greater than zero were suppressed and identified with an asterisk (*). Next, secondary suppression is used to obfuscate the totals or sums with components, or addends that fall below the threshold for primary suppression. These totals are typically reported in the margins of table rows and columns. Column or row totals that contained a non-zero addend less than 6 were rounded to the nearest tens-unit and identified with a dagger (†). In certain cases where these rules would have dictated the rounding of a row or column total but the value of the information contained in the total was identified as important or attainable from other sources, these rules were relaxed and the original value was reported.
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 1
Figure 1 Alzheimer’s Disease among the Leading Causes of Death
Arizona, 2017
The number of deaths from Alzheimer’s disease in Arizona in 2017 made Alzheimer’s disease the 5th leading cause of deaths for all ages. (Figure 1). More Arizonans died in 2017 from Alzheimer’s disease than they did from other chronic diseases, such as diabetes, chronic liver disease and cirrhosis, or nephritis (kidney disease).
Figure 2 Trends in Age-Adjusted Mortality Rates for Alzheimer’s
Disease and other Leading Causes of Death by Year, Arizona, 2000-2017
The trend in mortality from Alzheimer’s disease (Figure 2) reflects a number of factors such as 1) changes in attitudes ofphysicians and the public aboutattributing Alzheimer’s disease as acause of death, 2) availability ofimproved diagnostic procedures, 3)increase in the number of deathsattributed to Alzheimer’s diseasedue to changes in coding andclassification of causes of mortality,4) decreases in several otherleading causes of death (homicide,diabetes, suicide, atherosclerosis).
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 3
The age-adjusted mortality rate for Alzheimer’s disease increased by 61.5 percent from 21.8/100,000 in 2000 to 35.2/100,000 in 2017 (Figure 3). Among males, the age-adjusted mortality rate for Alzheimer’s disease increased by 66.9 percent during that time.
In 2000, the risk that a female will die from Alzheimer’s was 38.3 percent greater than the male mortality risk. In 2017, however, the female-to-male mortality ratio has diminished to 35.3 percent.
Figure 3 Age-Adjusted Mortality Rates for Alzheimer’s Disease
by Gender and Year, Arizona, 2000-2017
The 2017 death rate for Alzheimer’s disease among White non-Hispanic females was the highest among race/gender groups in Arizona (Figure 4). Black and White non-Hispanics had the highest death rates for Alzheimer’s disease among males.
White non-Hispanic females accounted for 1,667 deaths from Alzheimer’s disease (or 84 percent of all Alzheimer’s deaths among Arizona females), while White non-Hispanic males accounted for 937 deaths (or 87.1 percent of all Alzheimer’s deaths).
Figure 4 Age-Adjusted Mortality Rates for Alzheimer’s Disease
by Gender and Race/Ethnic Group, Arizona, 2017
4 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
Figure 5 Age-Specific Mortality Rates for Alzheimer’s Disease
among Arizonans Aged 55 Years and Older, 2017
Risk of death from Alzheimer’s disease increases sharply with age (Figure 5). In 2000, nine out of every ten deaths from Alzheimer’s disease were to persons aged 75 years and older. Similarly in 2017, the risk of death from Alzheimer’s was greater for Arizonans aged 75 years or older.
Figure 6 Mortality and Mortality Rates for Alzheimer’s Disease among
Arizona Elderly Residents 65 Years and Older, 2007-2017
The number of Alzheimer’s deaths has increased from 2007 to 2017, in part due to a growing population of older adults. Mortality rate from Alzheimer’s disease follows the same trajectory, marked by a 5.2 percent increase from 2007 to 2017 (Figure 6).
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 5
The death rate for Alzheimer’s disease, the third leading cause of elderly female mortality in Arizona in 2017, almost doubled from 191.6/100,000 in 2000 to 306.0/100,000 in 2017 (Figure 7). For elderly males, the mortality rate for Alzheimer’s disease, their fourth leading cause of death, increased by 79.4 percent from 108.0/100,000 in 2000 to 193.7/100,000 in 2017. In 2000, the Alzheimer’s disease mortality risk of elderly females compared to males was 77.4 percent greater, while in 2017 the risk was 58.0 percent greater.
Figure 7 Mortality Rates for Alzheimer’s Disease by Gender and Year
among Arizona Elderly Residents 65 Years and Older, 2000-2017
Mortality rates for Alzheimer’s disease among Arizonans 75-84 years old were higher among females than males from 2000 to 2017 (Figure 8). In 2000, the Alzheimer’s disease mortality risk of elderly females compared to males in this age group was 17.4 percent greater (168.8 deaths per 100,000 females vs. 143.8 deaths per 100,000 males). In 2017, the female-to-male difference was 22.6 percent, a ratio greater than that of 2010.
Figure 8 Mortality Rates for Alzheimer’s Disease by Gender and Year
among Arizonans 75-84 Years Old, 2007-2017
6 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
Among Arizonans 85 years and older, the mortality rates for Alzheimer’s disease among females exceeded the male rates in every year from 2007 to 2017 (Figure 9). In 2007, the Alzheimer’s disease mortality risk of elderly females compared to males in this age group was 60.6 percent greater, while in 2017 the risk was 42.5 percent greater.
Figure 9 Mortality Rates for Alzheimer’s Disease by Gender and Year
among Arizonans 85 Years and Older, 2007-2017
In 2017, Alzheimer’s disease had the highest average age at death of 87.0 years, exceeding the average age at death for all causes by 14.4 years (Figure 10). Only 16.1 percent of deaths from Alzheimer’s disease occurred before the age of 78.8 years, i.e., before the expected years of life were reached.
Figure 10 Average Age at Death for Selected Leading Causes
of Death, Arizona, 2017
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 7
Figure 11 Percent of Elderly 65+ by Race/Ethnicity and Proportional
Contribution to Mortality from Alzheimer’s Disease, Arizona, 2017
White non-Hispanic elderly residents of Arizona disproportionately contributed to total mortality from Alzheimer’s disease. In 2017, White non-Hispanics accounted for 80.9 percent of all elderly 65 years and older, but 85.6 percent of all deaths from Alzheimer’s disease (Figure 11).
White non-Hispanic residents of the State may be at higher risk for Alzheimer’s disease because they live longer than the other race/ethnic groups. In 2017, White non-Hispanics were the only group with about 50 percent of all deaths occurring before the expected years of life were reached. The 2017 premature death ratio was 43.3 percent for White non-Hispanic females and 57 percent for White non-Hispanic males. In contrast, at least 70 percent of deaths among ethnic minorities occurred prematurely.
Figure 12 Age-Adjusted Mortality Rates for Alzheimer’s Disease
by Gender in Urban and Rural Areas, Arizona, 2017
In 2017, the mortality rate for Alzheimer’s disease was 8.2 percent higher for urban (35.7/100,000) than rural (33.0/100,000) residents of the State (Figure 12). The mortality disadvantage of the urban compared to rural residents was particularly pronounced among females. The 2017 rate of the urban females was 11.3 percent greater than the rate of the rural females (40.3/100,000 vs. 36.2/100,000).
8 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
Coconino 21.0
Mohave 39.1
Navajo 29.6
Yavapai 46.6
Maricopa 38.6
16.3
Yuma 19.7
Graham 34.4
0.0 - 20.1
21.0 - 34.4
34.7 - 62.8
16.9
Apache 20.1
Figure 13 Age-Adjusted Mortality Rates* for Alzheimer’s Disease by County of Residence,
Arizona, 2017
Source: Population Health and Vital Statistics, ADHS*Per 100,000 population age-adjusted to the 2000 U.S. standard.
Gre
enle
e 6
2.8
Santa Cruz 25.9
In 2017, mortality from Alzheimer’s disease among the fifteen Arizona counties ranged from a rate of 11.7 deaths per 100,000 persons in La Paz County to a rate of 46.6 deaths per 100,000 persons in Yavapai County (Figure 13). Maricopa and Yavapai counties, which accounted for approximately half of the total population of the State, made a substantially higher contribution to mortality from Alzheimer’s disease (2,015 out of 3,050 deaths, or 66.1 percent of all deaths from Alzheimer’s disease). These two counties accounted for 60.4 percent of all Arizonans 85 years and older in the State, the group at the highest risk of death from Alzheimer’s disease.
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 9
MORTALITY FROM ALZHEIMER’S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
DATA TABLES
Cau
se o
f d
eath
Ran
k
(cou
nt)
in
20
00
Ran
k (c
oun
t)
in 2
00
1
Ran
k
(cou
nt)
in
20
02
Ran
k
(cou
nt)
in
20
03
Ran
k (c
oun
t)
in 2
00
4
Ran
k (c
oun
t)
in 2
00
5
Ran
k (c
oun
t)
in 2
00
6
Ran
k (c
oun
t)
in 2
00
7
Ran
k (c
oun
t)
in 2
00
8
Ran
k (c
oun
t)
in 2
00
9
Ran
k (c
oun
t)
in 2
01
0
Ran
k (c
oun
t)
in 2
01
1
Ran
k (c
oun
t)
in 2
01
2
Ran
k (c
oun
t)
in 2
01
3
Ran
k (c
oun
t)
in 2
01
4
Ran
k (c
oun
t)
in 2
01
5
Ran
k (c
oun
t)
in 2
01
6
Ran
k (c
oun
t)
in 2
01
7
Dis
ease
s of
hea
rt1
(1
0,43
0)1
(1
0,31
2)1
(1
0,55
1)1
(1
0,64
9)1
(1
0,40
2)1
(1
0,77
9)1
(1
0,36
2)1
(1
0,14
7)1
(1
0,29
9)1
(1
0,15
1)2
(9
,719
)2
(1
0,42
4)2
(1
0,36
6)2
(1
0,49
7)2
(9
,953
)2
(1
1,27
4)1
(1
1,82
0)1
(1
2,28
5)
Mal
ign
ant
neo
pla
sms
2
(8,9
94)
2
(8,9
14)
2
(9,1
48)
2
(9,4
51)
2
(9,5
06)
2
(9,6
73)
2
(9,7
68)
2
(9,9
55)
2
(9,9
49)
2
(10,
147)
1
(10,
423)
1
(10,
543)
1
(10,
871)
1
(11,
193)
1
(10,
600)
1
(11,
624)
2
(11,
801)
2
(11,
917)
Ch
ron
ic lo
wer
res
pir
ator
y d
isea
ses
4
(2,4
93)
3
(2,4
63)
3
(2,5
30)
3
(2,5
22)
5
(2,3
92)
4
(2,7
78)
4
(2,7
71)
4
(2,6
51)
4
(2,8
96)
4
(2,8
08)
3
(2,8
92)
3
(3,1
43)
3
(3,1
67)
3
(3,2
95)
3
(3,1
85)
3
(3,6
48)
4
(3,7
88)
4
(3,7
79)
Cer
ebro
vasc
ula
r d
isea
ses
3
(2,6
03)
5
(2,4
16)
4
(2,4
48)
5
(2,3
56)
4
(2,4
12)
5
(2,3
25)
5
(2,1
59)
5
(2,0
79)
5
(2,0
89)
6
(2,0
10)
6
(2,0
51)
6
(2,0
67)
6
(2,0
96)
6
(2,0
47)
6
(1,9
95)
6
(2,4
63)
6
(2,5
36)
6
(2,6
47)
Acc
iden
ts (
un
inte
nti
onal
in
jury
)5
(2
,087
)4
(2
,430
)5
(2
,416
)4
(2
,466
)3
(2
,641
)3
(3
,006
)3
(3
,156
)3
(3
,014
)3
(2
,951
)3
(2
,887
)4
(2
,834
)4
(2
,959
)4
(2
,804
)4
(3
,137
)4
(3
,011
)4
(3
,403
)3
(3
,899
)3
(4
,085
)
Alz
hei
mer
's d
isea
se7
(1
,046
)6
(1
,103
)6
(1
,413
)6
(1
,691
)6
(1
,672
)6
(1
,816
)6
(2
,057
)6
(2
,041
)6
(2
,086
)5
(2
,086
)5
(2
,314
)5
(2
,336
)5
(2
,154
)5
(2
,384
)5
(2
,345
)5
(2
,942
)5
(3
,081
)5
(3
,050
)
Infl
uen
za a
nd
pn
eum
onia
6
(1,2
01)
7
(1,1
00)
7
(1,2
94)
7
(1,2
48)
8
(1,1
08)
7
(1,2
80)
8
(1,1
47)
9
(8
75)
8
(1,0
75)
9
(1,0
07)
10
(7
29)
11
(6
49)
11
(6
35)
10
(7
24)
11
(6
69)
11
(7
39)
11
(8
59)
11
(8
52)
Dia
bet
es8
(9
93)
8
(1,0
40)
8
(1,2
01)
8
(1,1
24)
7
(1,1
80)
8
(1,1
96)
7
(1,1
88)
7
(1,1
45)
7
(1,1
62)
7
(1,0
78)
7
(1,3
72)
7
(1,7
21)
7
(1,6
98)
7
(1,7
44)
7
(1,7
76)
7
(2,0
50)
7
(2,0
13)
7
(2,0
37)
Inte
nti
onal
sel
f-h
arm
(s
uic
ide)
9
(737
)9
(767
)9
(8
55)
9
(807
)9
(8
54)
9
(915
)9
(9
48)
8
(9
86)
9
(9
68)
8
(1,0
60)
8
(1,0
70)
8
(1,1
13)
8
(1,0
70)
8
(1,1
16)
8
(1,1
24)
8
(1,2
33)
8
(1,2
56)
8
(1,3
04)
Ch
ron
ic li
ver
dis
ease
an
d
cirr
hos
is1
0
(6
45)
10
(635
)1
0
(6
47)
10
(625
)1
0
(6
29)
10
(749
)1
0
(7
06)
10
(734
)1
0
(7
78)
10
(818
)9
(843
)9
(9
33)
9
(9
71)
9
(1,0
40)
9
(984
)9
(1
,120
)9
(1
,169
)9
(1
,122
)
Esse
nti
al p
rim
ary
hyp
erte
nsi
on/
hyp
er-
ten
sive
ren
al d
isea
se
11
(275
)1
1
(2
98)
11
(293
)1
1
(3
39)
11
(405
)1
1
(3
90)
11
(420
)1
1
(3
89)
11
(475
)1
1
(4
75)
11
(498
)1
0
(7
25)
10
(739
)1
1
(7
11)
10
(758
)1
0
(8
96)
10
(1
,010
)1
0
(1,0
18)
ALL
CA
US
ES40
,202
40,8
5142
,320
42,8
3042
,736
45,1
1545
,415
44,6
4045
,128
45,0
6545
,871
47,5
4748
,459
49,9
2951
,074
54,1
5256
,480
57,2
61
TAB
LE 1
NU
MB
ER O
F D
EATH
S F
RO
M A
LZH
EIM
ER'S
DIS
EAS
E A
ND
OTH
ER L
EAD
ING
CA
US
ES O
F M
OR
TALI
TY B
Y Y
EAR
, A
RIZ
ON
A,
20
00
-20
17
Not
es:
The
cau
se-o
f-de
ath
titles
are
acc
ordi
ng t
o th
e Te
nth
Rev
isio
n of
the
Int
erna
tion
al C
lass
ifica
tion
of
Dis
ease
s (I
CD
-10)
; th
e ca
use
of d
eath
for
200
0 ar
e cl
assi
fied
by I
CD
-10,
rep
laci
ng t
he N
inth
Rev
isio
n (I
CD
-9)
used
dur
ing
1979
-199
9;
the
grou
p titles
, su
ch a
s Car
diov
ascu
lar
dise
ases
, In
fect
ious
and
par
asitic
dis
ease
s or
oth
er c
ardi
ovas
cula
r di
seas
es a
re n
ot r
anke
d to
det
erm
ine
the
lead
ing
caus
es o
f de
ath.
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 13
Cau
se o
f d
eath
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
Dis
ease
s of
hea
rt20
6.1
201.
720
1.0
197.
118
6.7
186.
916
6.1
149.
514
9.3
145.
914
3.3
152.
714
5.8
143.
012
9.9
141.
314
2.5
141.
9
Mal
ign
ant
neo
pla
sms
170.
416
9.2
168.
616
9.4
164.
716
1.8
154.
714
8.0
145.
514
7.2
150.
515
1.3
149.
814
9.6
136.
314
4.0
140.
713
6.6
Ch
ron
ic lo
wer
res
pir
ator
y d
isea
ses
47.4
46.9
47.0
45.4
41.9
46.8
44.3
39.2
42.1
40.5
42.6
45.9
44.2
44.5
41.1
45.1
45.0
43.0
Cer
ebro
vasc
ula
r d
isea
ses
51.7
47.7
47.0
43.9
43.6
40.6
34.8
30.6
30.3
28.9
30.7
30.6
29.9
28.2
26.2
31.1
30.7
30.7
Acc
iden
ts (
un
inte
nti
onal
in
jury
)41
.146
.645
.244
.846
.051
.151
.246
.644
.743
.143
.845
.542
.446
.343
.348
.153
.755
.3
Alz
hei
mer
's d
isea
se21
.822
.528
.032
.531
.332
.733
.429
.629
.829
.535
.135
.229
.933
.230
.937
.337
.335
.2
Infl
uen
za a
nd
pn
eum
onia
24.4
21.9
25.0
23.4
20.1
22.3
18.4
12.9
15.6
14.6
10.9
9.7
9.1
10.0
8.9
9.4
10.4
9.9
Dia
bet
es19
.019
.922
.320
.320
.720
.118
.917
.017
.015
.720
.124
.823
.523
.623
.025
.724
.523
.8
Inte
nti
onal
sel
f-h
arm
(s
uic
ide)
14.6
14.9
15.9
14.6
14.9
15.4
15.4
15.4
14.8
16.1
16.7
17.2
16.2
17.0
16.5
17.8
17.7
18.0
Ch
ron
ic li
ver
dis
ease
an
d
cirr
hos
is12
.812
.312
.111
.511
.112
.711
.411
.311
.712
.212
.313
.413
.614
.513
.214
.915
.114
.2
Tota
l, a
ll ca
use
s78
5.6
791.
279
6.4
784.
075
7.3
772.
572
7.3
663.
265
9.6
653.
267
9.9
699.
668
7.2
687.
867
6.0
691.
369
6.6
679.
3
TAB
LE 2
AG
E-A
DJU
STE
D M
OR
TALI
TY R
ATE
Sa FO
R A
LZH
EIM
ER
'S D
ISEA
SE
AN
D O
THER
LEA
DIN
G C
AU
SES
OF
DEA
TH
, A
RIZ
ON
A,
20
00
-20
17
Not
es:
The
num
ber
of d
eath
s pe
r 10
0,00
0 po
pula
tion
adj
uste
d to
the
200
0 U
.S.
stan
dard
; th
e ca
use-
of-d
eath
title
s ar
e ac
cord
ing
to t
he T
enth
Rev
isio
n of
the
Int
erna
tion
al C
lass
ifica
tion
of
Dis
ease
s (I
CD
-10)
; th
e ca
uses
of
dea
th f
or 2
000
are
clas
sifie
d by
ICD
-10;
the
cau
ses
of d
eath
for
199
8-19
99 a
re c
lass
ified
by
the
Nin
th R
evis
ion
(ICD
-9);
a The
rat
es a
re p
er 1
00,0
00 p
opul
atio
n.
14 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
Tota
l21
.822
.528
.032
.531
.332
.733
.429
.629
.829
.535
.135
.229
.933
.230
.937
.337
.335
.2
Mal
e17
.518
.423
.426
.626
.427
.727
.022
.823
.924
.528
.528
.941
.527
.225
.731
.131
.129
.2
Fem
ale
24.2
25.1
30.5
35.9
34.2
35.7
37.4
34.1
33.6
32.8
39.3
39.0
52.8
37.2
34.4
41.5
41.5
39.5
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
Tota
l1,
046
1,10
31,
413
1,69
11,
672
1,81
62,
057
2,04
12,
086
2,08
62,
314
2,33
62,
154
2,38
42,
345
2,94
23,
081
3,05
0
Mal
e32
633
745
353
053
258
964
163
367
569
775
377
474
879
280
71,
028
1,08
41,
076
Fem
ale
720
766
960
1,16
11,
140
1,22
71,
416
1,40
81,
411
1,38
91,
561
1,56
21,
406
1,59
21,
538
1,91
41,
997
1,97
4
TAB
LE 3
AG
E-A
DJU
STE
D M
OR
TALI
TY R
ATE
Sa FO
R A
LZH
EIM
ER
'S D
ISE
AS
E B
Y G
EN
DE
R A
ND
YE
AR
, A
RIZ
ON
A,
20
00
-20
17
Not
es:
The
num
ber
of d
eath
s pe
r 10
0,00
0 po
pula
tion
adju
sted
to
the
2000
U.S
. st
anda
rd;
a th
e ra
tes
are
per
100,
000
pers
ons
in s
peic
ifed
grou
p.
TAB
LE 4
NU
MB
ER
OF
DE
ATH
S F
RO
M A
LZH
EIM
ER
'S D
ISE
AS
E B
Y G
EN
DE
R A
ND
YE
AR
, A
RIZ
ON
A,
20
00
-20
17
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 15
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
Tota
l1,
046
1,10
31,
413
1,69
11,
672
1,81
62,
057
2,04
12,
086
2,08
62,
314
2,33
62,
154
2,38
42,
345
2,94
23,
081
3,05
0
Mal
e32
633
745
353
053
258
964
163
367
569
775
377
474
879
280
71,
028
1,08
41,
076
Fem
ale
720
766
960
1,16
11,
140
1,22
71,
416
1,40
81,
411
1,38
91,
561
1,56
21,
406
1,59
21,
538
1,91
41,
997
1,97
4
Tota
l95
91,
020
1,29
41,
547
1,52
71,
638
1,86
91,
836
1,85
01,
854
2,01
32,
038
1,86
92,
042
1,99
32,
515
2,61
72,
604
Mal
e29
730
940
749
048
552
457
756
760
462
764
867
565
867
769
587
894
093
7
Fem
ale
662
711
887
1,05
71,
042
1,11
41,
292
1,26
91,
246
1,22
71,
365
1,36
31,
211
1,36
51,
298
1,63
71,
677
1,66
7
Tota
l64
4987
101
9911
813
514
215
416
019
118
219
925
225
330
231
332
1
Mal
e22
2131
2630
4750
5147
5066
5770
8281
113
9596
Fem
ale
4228
5675
6971
8591
107
110
125
125
129
170
172
189
218
225
Tota
l13
1518
3331
3227
3753
3849
5841
4749
6572
64
Mal
e5
08
1411
65
815
1019
2113
1519
1923
26
Fem
ale
815
1019
2026
2229
3828
3037
2832
3046
4938
Tota
l7
129
68
1720
1614
1820
2620
†25
3734
4423
Mal
e2
33
04
68
44
57
8*
1111
1314
6
Fem
ale
59
66
411
1212
1013
1318
1314
2621
3017
Tota
l2
55
46
105
913
1325
1730
†18
10†
30†
3530
†
Mal
e0
34
02
51
23
47
7*
7*
*12
*
Fem
ale
22
14
45
47
109
1810
2511
1221
2322
Tota
l1
00
00
00
00
00
00
00
00
0
Mal
e0
00
00
00
00
00
00
00
00
0
Fem
ale
10
00
00
00
00
00
00
00
00
Not
es:
* ce
ll su
ppre
ssed
due
to
non-
zero
cou
nt le
ss t
han
6; †
sum
rou
nded
to
near
est
tens
uni
t du
e to
non
-zer
o ad
dend
less
tha
n 6.
Bla
ck o
r A
fric
an
Am
eric
an
Am
eric
an
Ind
ian
or
Ala
ska
Nat
ive
Asi
an o
r P
acif
ic
Isla
nd
er
Ref
use
d/
Un
know
n
TAB
LE 5
NU
MB
ER O
F D
EATH
S F
RO
M A
LZH
EIM
ER'S
DIS
EAS
E B
Y R
AC
E/ET
HN
ICIT
Y A
ND
GEN
DER
, A
RIZ
ON
A,
20
00
-20
17
All
gro
up
s
Wh
ite
non
-H
isp
anic
His
pan
ic o
r La
tin
o
16 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
20
00
20
07
20
10
20
17
Tota
l1,
046
2,04
12,
314
3,05
0
Mal
e32
663
375
31,
076
Fem
ale
720
1,40
81,
561
1,97
4
Tota
l89
11,
758
1,99
82,
505
Mal
e26
354
065
186
2
Fem
ale
628
1,21
81,
346
1,64
3
Tota
l15
528
331
453
7
Mal
e63
9310
020
8
Fem
ale
9219
021
432
9
TAB
LE 6
NU
MB
ER O
F D
EATH
S F
RO
M A
LZH
EIM
ER'S
DIS
EAS
E B
Y U
RB
AN
/R
UR
AL
AR
EA A
ND
GEN
DER
, A
RIZ
ON
A,
20
00
, 2
00
7,
20
10
, A
ND
20
17
Ru
ral
All
gro
up
s
Urb
an
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 17
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
Tota
l S
tate
1,04
61,
103
1,41
31,
691
1,67
21,
816
2,05
72,
041
2,08
62,
086
2,31
42,
336
2,15
0†2,
380†
2,35
0†2,
940†
3,08
0†3,
050
Ap
ach
e5
27
46
57
810
58
8*
8*
1312
14
Coc
his
e26
1738
3241
3327
2637
3433
3627
3119
4241
33
Coc
onin
o8
312
159
1215
1211
1313
2011
1819
2234
23
Gil
a 8
1116
3736
3939
3340
2523
2427
2530
3722
17
Gra
ham
35
35
44
64
94
27
9*
69
1012
Gre
enle
e1
00
01
00
11
02
0*
**
**
6
La P
az0
11
42
33
61
34
3*
0*
*9
7
Mar
icop
a67
972
193
61,
103
1,11
31,
246
1,44
51,
453
1,45
91,
481
1,66
51,
732
1,52
31,
555
1,46
71,
772
1,83
51,
796
Moh
ave
2931
4082
6751
8970
7863
8556
4942
6197
116
154
Nav
ajo
1020
1314
1414
2921
1820
1518
1619
3427
2735
Pim
a18
318
221
324
423
425
421
922
624
624
623
521
529
047
748
953
757
652
9
Pin
al19
3145
3658
3852
6470
6677
8971
8592
160
116
116
San
ta C
ruz
74
1110
36
914
1010
108
1316
1210
1817
Yav
apai
5861
6593
7395
110
8881
9611
992
9780
6815
220
021
9
Yu
ma
1014
1312
1116
715
1415
2120
922
3653
5564
Un
know
n0
00
00
00
01
52
8*
**
*8
8
TAB
LE 7
NU
MB
ER O
F D
EATH
S F
RO
M A
LZH
EIM
ER'S
DIS
EAS
E B
Y C
OU
NTY
OF
RES
IDEN
CE
AN
D Y
EAR
, A
RIZ
ON
A,
20
00
-20
17
Not
es:
* ce
ll su
ppre
ssed
due
to
non-
zero
cou
nt le
ss t
han
6; †
sum
rou
nded
to
near
est
tens
uni
t du
e to
non
-zer
o ad
dend
less
tha
n 6.
18 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
20
00
20
07
20
10
20
17
Tota
l1,
046
2,03
52,
313
3,05
0
Mal
e32
663
175
21,
076
Fem
ale
720
1,40
41,
560
1,97
4
Un
know
n0
01
0
Tota
l0
00
0†
Mal
e0
00
0
Fem
ale
00
00
Tota
l0
21
0†
Mal
e0
00
0
Fem
ale
02
1*
Tota
l14
1912
51
Mal
e6
75
24
Fem
ale
812
727
Tota
l62
104
124
218
Mal
e27
5262
83
Fem
ale
3552
6213
5
Tota
l37
263
165
688
2
Mal
e14
622
525
336
7
Fem
ale
226
406
403
515
Tota
l59
81,
278
1,52
01,
897
Mal
e14
734
743
260
2
Fem
ale
451
931
1,08
71,
295
Un
know
n0
01
0
Tota
l0
10
0
Mal
e0
00
0
Fem
ale
01
00
Not
es:
* ce
ll su
ppre
ssed
due
to
non-
zero
cou
nt le
ss t
han
6; †
sum
rou
nded
to
near
est
tens
uni
t du
e to
non
-zer
o ad
dend
less
tha
n 6.
TAB
LE 8
NU
MB
ER O
F D
EATH
S F
RO
M A
LZH
EIM
ER'S
DIS
EAS
E B
Y A
GE
GR
OU
P A
ND
GEN
DER
, A
RIZ
ON
A,
20
00
, 2
00
7,
20
10
, A
ND
20
17
Tota
l, a
ll ag
es
85
+
Un
know
n
35
-44
45
-54
55
-64
65
-74
75
-84
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 19
Cau
se o
f d
eath
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
Tota
l, a
ll ca
use
s29
,323
29,5
0430
,553
30,8
1530
,532
32,1
6332
,192
31,5
8232
,214
32,0
9832
,876
34,3
1834
,958
35,9
8337
,010
39,4
8041
,189
42,1
99
Dis
ease
s of
hea
rt8,
702
8,55
68,
676
8,81
98,
495
8,74
18,
343
8,15
58,
218
8,17
27,
852
8,40
78,
449
8,58
38,
130
9,18
99,
673
10,1
71
Mal
ign
ant
neo
pla
sms
6,49
96,
351
6,44
86,
748
6,72
66,
874
6,92
57,
033
7,07
17,
227
7,42
17,
513
7,72
98,
015
7,71
58,
502
8,68
68,
850
Ch
ron
ic lo
wer
res
pir
ator
y d
isea
ses
2,21
12,
141
2,22
92,
234
2,10
42,
403
2,43
02,
303
2,51
62,
460
2,55
82,
745
2,74
62,
868
2,74
33,
192
3,28
63,
293
Cer
ebro
vasc
ula
r d
isea
se2,
315
2,14
82,
188
2,09
82,
123
2,03
41,
839
1,77
01,
789
1,73
61,
784
1,78
21,
774
1,73
61,
739
2,12
72,
236
2,29
2
Alz
hei
mer
's d
isea
se1,
032
1,09
21,
400
1,67
81,
664
1,80
12,
036
2,01
92,
061
2,06
42,
301
2,30
72,
129
2,35
32,
311
2,90
33,
048
2,99
7
Infl
uen
za a
nd
pn
eum
onia
1,02
794
11,
100
1,04
794
01,
050
923
724
856
786
585
533
542
608
512
626
670
697
Dia
bet
es71
672
387
680
182
185
380
777
979
774
493
01,
193
1,14
81,
162
1,18
81,
345
1,36
21,
411
Acc
iden
ts (
un
inte
nti
onal
in
jury
)65
269
675
275
085
498
697
198
21,
007
980
1,01
81,
070
999
1,14
61,
145
1,29
81,
463
1,48
5
Nep
hri
tis,
nep
hro
tic
syn
dro
me
and
nep
hro
sis
507
493
489
431
489
483
426
416
391
414
407
340
373
328
288
430
403
445
Par
kin
son
’s d
isea
se33
835
738
739
538
247
348
244
347
743
348
052
656
556
155
870
069
773
7
TAB
LE 9
ALZ
HEI
MER
'S D
ISEA
SE
AN
D O
THER
LEA
DIN
G C
AU
SES
OF
DEA
TH A
MO
NG
ELD
ERLY
65
YEA
RS
AN
D O
LDER
, B
Y Y
EAR
, A
RIZ
ON
A,
20
00
-20
17
20 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
Cau
se o
f d
eath
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
Tota
l, a
ll ca
use
s14
,107
14,1
8214
,733
14,7
4414
,614
15,3
8515
,273
14,9
8115
,589
15,4
6215
,967
16,5
1717
,101
17,4
8918
,292
19,6
6520
,781
21,1
44
Dis
ease
s of
hea
rt4,
372
4,22
44,
309
4,34
04,
182
4,33
04,
061
4,03
94,
241
4,12
23,
988
4,31
04,
384
4,51
14,
280
4,79
85,
187
5,44
6
Mal
ign
ant
neo
pla
sms
3,47
23,
345
3,53
73,
660
3,65
83,
734
3,77
43,
819
3,83
23,
907
4,04
84,
075
4,25
74,
294
4,23
54,
609
4,79
84,
854
Ch
ron
ic lo
wer
res
pir
ator
y d
isea
ses
1,09
41,
036
1,11
31,
108
997
1,10
91,
165
1,12
61,
206
1,16
61,
249
1,28
81,
372
1,35
61,
367
1,52
71,
542
1,56
6
Alz
hei
mer
's d
isea
se32
033
244
752
552
958
163
162
666
468
674
876
373
578
179
21,
005
1,07
31,
052
Cer
ebro
vasc
ula
r d
isea
se91
884
985
180
981
678
669
663
171
970
268
066
571
068
068
090
591
497
0
Dia
bet
es31
433
842
338
337
144
541
138
541
136
649
862
662
463
365
573
778
379
5
Acc
iden
ts (
un
inte
nti
onal
in
jury
)32
837
738
836
340
247
747
746
550
748
850
650
547
456
357
067
577
976
6
Par
kin
son
’s d
isea
se19
521
424
922
324
128
628
926
029
527
529
031
035
935
833
644
245
547
0
Infl
uen
za a
nd
pn
eum
onia
479
447
474
525
471
492
454
348
406
351
289
262
263
285
252
312
331
339
Nep
hri
tis,
nep
hro
tic
syn
dro
me
and
nep
hro
sis
247
275
223
205
251
248
207
201
202
215
207
173
178
157
135
228
204
236
ALZ
HEI
MER
'S D
ISEA
SE
AN
D O
THER
LEA
DIN
G C
AU
SES
OF
DEA
TH A
MO
NG
ELD
ERLY
FEM
ALE
S 6
5 Y
EAR
S A
ND
OLD
ER,
BY
YEA
R,
AR
IZO
NA
, 2
00
0-2
01
7
Cau
se o
f d
eath
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
Tota
l, a
ll ca
use
s15
,216
15,3
2215
,820
16,0
7015
,918
16,7
7816
,919
16,6
0116
,625
16,6
3616
,909
17,7
9817
,855
18,4
9418
,718
19,8
1520
,408
21,0
55
Dis
ease
s of
hea
rt4,
330
4,33
24,
367
4,47
94,
313
4,41
14,
282
4,11
64,
037
4,05
03,
864
4,09
64,
065
4,07
23,
850
4,39
14,
486
4,72
5
Mal
ign
ant
neo
pla
sms
3,02
73,
006
2,91
13,
087
3,06
83,
140
3,15
13,
214
3,24
13,
320
3,37
33,
437
3,47
23,
721
3,48
03,
893
3,88
83,
996
Ch
ron
ic lo
wer
res
pir
ator
y d
isea
ses
1,11
71,
105
1,11
61,
126
1,10
71,
294
1,26
51,
177
1,31
01,
294
1,30
91,
457
1,37
41,
512
1,37
61,
665
1,74
41,
727
Alz
hei
mer
's d
isea
se71
276
095
31,
153
1,13
51,
220
1,40
51,
393
1,39
71,
378
1,55
31,
544
1,39
41,
572
1,51
91,
898
1,97
51,
945
Cer
ebro
vasc
ula
r d
isea
se1,
397
1,29
91,
337
1,28
91,
307
1,24
81,
143
1,13
91,
075
1,03
41,
104
1,11
71,
064
1,05
61,
059
1,22
21,
322
1,32
2
Dia
bet
es40
238
545
341
845
040
839
639
438
737
843
256
752
452
953
360
857
961
6
Acc
iden
ts (
un
inte
nti
onal
in
jury
)32
431
936
438
745
250
949
451
751
949
251
256
552
558
357
562
368
471
9
Par
kin
son
’s d
isea
se14
314
313
817
214
118
719
318
318
215
819
021
620
620
322
225
824
226
7
Infl
uen
za a
nd
pn
eum
onia
548
494
626
522
469
558
469
376
452
435
296
271
279
323
260
314
339
358
Nep
hri
tis,
nep
hro
tic
syn
dro
me
and
nep
hro
sis
260
218
266
226
238
235
219
215
190
199
200
167
195
171
153
202
199
209
TAB
LE 1
0A
LZH
EIM
ER'S
DIS
EAS
E A
ND
OTH
ER L
EAD
ING
CA
US
ES O
F D
EATH
AM
ON
G E
LDER
LY M
ALE
S 6
5 Y
EAR
S A
ND
OLD
ER,
BY
YEA
R,
AR
IZO
NA
, 2
00
0-2
01
7
TAB
LE 1
1
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 21
Mal
e Fe
mal
eU
rban
Ru
ral
Un
-kn
own
Wh
ite
non
-H
isp
anic
His
pan
ic
or L
atin
o
Bla
ck o
r A
fric
an
Am
eric
an
Am
eric
an
Ind
ian
or
Ala
ska
Nat
ive
Asi
an o
r P
acif
ic
Isla
nd
er
Oth
er/
U
nkn
own
Tota
l, a
ll c
ause
s42
,199
21,1
4421
,055
33,1
468,
905
148
34,9
644,
407
975
1,06
255
723
4
Dis
ease
s of
hea
rt10
,171
5,44
64,
725
7,87
72,
258
368,
585
956
220
214
127
69
Mal
ign
ant
neo
pla
sms
8,85
04,
854
3,99
66,
919
1,90
328
7,45
584
721
616
012
844
Ch
ron
ic l
ower
res
pir
ator
y d
isea
ses
3,29
31,
566
1,72
72,
490
789
142,
982
178
4237
3123
Alz
hei
mer
's d
isea
se2,
997
1,05
21,
945
2,46
552
48
2,56
531
261
2225
12
Cer
ebro
vasc
ula
r d
isea
se2,
292
970
1,32
21,
819
465
81,
840
289
7350
337
Acc
iden
ts (
un
inte
nti
onal
in
jury
)1,
485
766
719
1,13
534
010
1,17
616
932
6428
16
Dia
bet
es1,
411
795
616
1,12
028
6*
898
302
6111
331
6
Esse
nti
al (
pri
mar
y) h
yper
ten
sion
an
d
hyp
erte
nsi
ve d
isea
se85
037
747
374
011
00
650
122
3721
17*
Par
kin
son
’s d
isea
se73
747
026
760
613
0*
637
577
1715
*
Infl
uen
za a
nd
pn
eum
onia
697
339
358
530
163
*54
496
1334
8*
Not
e: *
cel
l sup
pres
sed
due
to n
on-z
ero
coun
t le
ss t
han
6.
TAB
LE 1
2A
LZH
EIM
ER
'S D
ISE
AS
E A
ND
OTH
ER
LE
AD
ING
CA
US
ES
OF
DE
ATH
AM
ON
G E
LDE
RLY
65
YE
AR
S A
ND
OLD
ER
, B
Y G
EN
DE
R,
AR
EA
, A
ND
RA
CE
/E
THN
ICIT
Y,
AR
IZO
NA
, 2
01
7
Tota
l
Gen
der
Are
aR
ace/
Eth
nic
ity
Cau
se o
f d
eath
22 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
Mal
e Fe
mal
eU
rban
Ru
ral
Un
-kn
own
Wh
ite
non
-H
isp
anic
His
pan
ic
or L
atin
o
Bla
ck o
r A
fric
an
Am
eric
an
Am
eric
an
Ind
ian
or
Ala
ska
Nat
ive
Asi
an o
r P
acif
ic
Isla
nd
er
Oth
er/
U
nkn
own
Tota
l, a
ll c
ause
s11
,328
6,59
04,
738
8,67
42,
578
768,
956
1,32
437
538
715
013
6
Mal
ign
ant
neo
pla
sms
3,53
21,
987
1,54
52,
733
782
172,
909
366
116
6747
27
Dis
ease
s of
hea
rt2,
266
1,53
473
21,
650
595
211,
797
250
7864
3641
Ch
ron
ic l
ower
res
pir
ator
y d
isea
ses
952
513
439
708
235
986
245
157
617
Dia
bet
es55
332
422
944
210
8*
332
116
2761
12*
Cer
ebro
vasc
ula
r d
isea
se43
521
821
734
291
*32
466
2115
7*
Acc
iden
ts (
un
inte
nti
onal
in
jury
)42
127
614
530
410
98
300
5314
3111
12
Alz
hei
mer
's d
isea
se22
0†83
135
181
36*
188
22*
*0
*
Infl
uen
za a
nd
pn
eum
onia
150†
8864
116
35*
110
25*
9*
0
Par
kin
son
’s d
isea
se11
0†70
3889
190
8714
*0
**
Nep
hri
tis,
nep
hro
tic
syn
dro
me
and
n
eph
rosi
s10
0†57
4581
210
6222
88
*0
Not
e: *
cel
l sup
pres
sed
due
to n
on-z
ero
coun
t le
ss t
han
6.
TAB
LE 1
3A
LZH
EIM
ER
'S D
ISE
AS
E A
ND
OTH
ER
LE
AD
ING
CA
US
ES
OF
DE
ATH
AM
ON
G E
LDE
RLY
65
-74
YE
AR
S O
LD,
BY
GE
ND
ER
, A
RE
A,
AN
D R
AC
E/
ETH
NIC
ITY
, A
RIZ
ON
A,
20
17
Tota
l
Gen
der
Are
aR
ace/
Eth
nic
ity
Cau
se o
f d
eath
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 23
Mal
e Fe
mal
eU
rban
Ru
ral
Un
-kn
own
Wh
ite
non
-H
isp
anic
His
pan
ic
or L
atin
o
Bla
ck o
r A
fric
an
Am
eric
an
Am
eric
an
Ind
ian
or
Ala
ska
Nat
ive
Asi
an o
r P
acif
ic
Isla
nd
er
Oth
er/
U
nkn
own
Tota
l, a
ll c
ause
s14
,136
7,62
96,
507
10,9
203,
176
4011
,631
1,53
231
937
321
269
Mal
ign
ant
neo
pla
sms
3,30
91,
840
1,46
92,
554
747
82,
805
310
7457
4815
Dis
ease
s of
hea
rt3,
136
1,81
11,
325
2,37
475
48
2,59
733
166
8239
21
Ch
ron
ic l
ower
res
pir
ator
y d
isea
ses
1,31
563
268
397
533
6*
1,19
174
1515
16*
Alz
hei
mer
's d
isea
se88
236
751
573
614
4*
737
102
198
12*
Cer
ebro
vasc
ula
r d
isea
se75
438
337
157
717
3*
593
9526
2115
*
Dia
bet
es53
731
522
242
511
1*
335
131
2139
110
Acc
iden
ts (
un
inte
nti
onal
in
jury
)45
525
320
234
311
1*
357
5411
228
*
Par
kin
son
’s d
isea
se32
0†21
810
526
657
027
229
*11
**
Infl
uen
za a
nd
pn
eum
onia
210†
117
9317
138
*16
827
*8
**
Nep
hri
tis,
nep
hro
tic
syn
dro
me
and
n
eph
rosi
s16
0†10
355
107
510
123
16*
12*
0
Not
e: *
cel
l sup
pres
sed
due
to n
on-z
ero
coun
t le
ss t
han
6.
TAB
LE 1
4A
LZH
EIM
ER
'S D
ISE
AS
E A
ND
OTH
ER
LE
AD
ING
CA
US
ES
OF
DE
ATH
AM
ON
G E
LDE
RLY
75
-84
YE
AR
S O
LD,
BY
GE
ND
ER
, A
RE
A,
AN
D R
AC
E/
ETH
NIC
ITY
, A
RIZ
ON
A,
20
17
Tota
l
Gen
der
Are
aR
ace/
Eth
nic
ity
Cau
se o
f d
eath
24 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
Mal
e Fe
mal
eU
rban
Ru
ral
Un
-kn
own
Wh
ite
non
-H
isp
anic
His
pan
ic
or L
atin
o
Bla
ck o
r A
fric
an
Am
eric
an
Am
eric
an
Ind
ian
or
Ala
ska
Nat
ive
Asi
an o
r P
acif
ic
Isla
nd
er
Oth
er/
U
nkn
own
Tota
l, a
ll c
ause
s16
,735
6,92
59,
810
13,5
523,
151
3214
,377
1,55
128
130
219
529
Dis
ease
s of
hea
rt4,
769
2,10
12,
668
3,85
390
97
4,19
137
576
6852
7
Mal
ign
ant
neo
pla
sms
2,00
91,
027
982
1,63
237
4*
1,74
117
126
3633
*
Alz
hei
mer
's d
isea
se1,
897
602
1,29
51,
548
344
*1,
640
188
3812
136
Cer
ebro
vasc
ula
r d
isea
se1,
103
369
734
900
201
*92
312
826
1411
*
Ch
ron
ic l
ower
res
pir
ator
y d
isea
ses
1,02
642
160
580
721
8*
929
5912
159
*
Acc
iden
ts (
un
inte
nti
onal
in
jury
)60
923
737
248
812
0*
519
627
119
*
Infl
uen
za a
nd
pn
eum
onia
340†
134
201
243
90*
266
446
17*
*
Dia
bet
es32
115
616
525
367
*23
155
1313
8*
Par
kin
son
’s d
isea
se30
618
212
425
154
*27
814
06
7*
Nep
hri
tis,
nep
hro
tic
syn
dro
me
and
n
eph
rosi
s19
0†76
109
126
590
153
22*
**
0
Not
e: *
cel
l sup
pres
sed
due
to n
on-z
ero
coun
t le
ss t
han
6.
TAB
LE 1
5A
LZH
EIM
ER
'S D
ISE
AS
E A
ND
OTH
ER
LE
AD
ING
CA
US
ES
OF
DE
ATH
AM
ON
G E
LDE
RLY
85
YE
AR
S A
ND
OLD
ER
, B
Y G
EN
DE
R,
AR
EA
, A
ND
RA
CE
/E
THN
ICIT
Y,
AR
IZO
NA
, 2
01
7
Tota
l
Gen
der
Are
aR
ace/
Eth
nic
ity
Cau
se o
f d
eath
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 25
AG
E G
RO
UP
20
00
20
10
20
17
65
-74
363,
841
497,
892
687,
261
75
-84
235,
473
280,
539
353,
935
85
+68
,525
103,
400
137,
663
All
65
+66
7,83
988
1,83
11,
178,
859
65
-74
171,
689
236,
227
323,
376
75
-84
101,
550
127,
730
165,
009
85
+23
,028
37,7
3854
,847
All
65
+29
6,26
740
1,69
554
3,23
26
5-7
419
2,15
226
1,66
536
3,88
57
5-8
413
3,92
315
2,80
918
8,92
68
5+
45,4
9765
,662
82,8
16A
ll 6
5+
371,
572
480,
136
635,
627
65
-74
308,
175
403,
963
546,
079
75
-84
209,
934
235,
652
292,
108
85
+61
,153
90,2
3011
5,83
1A
ll 6
5+
579,
262
729,
845
954,
018
65
-74
146,
642
193,
910
259,
209
75
-84
90,9
3710
8,90
113
8,59
68
5+
20,4
5933
,046
46,7
68A
ll 6
5+
258,
038
335,
857
444,
573
65
-74
161,
533
210,
053
286,
870
75
-84
118,
997
126,
751
153,
512
85
+40
,694
57,1
8469
,063
All
65
+32
1,22
439
3,98
850
9,44
56
5-7
435
,070
57,4
7990
,432
75
-84
16,1
6028
,486
39,4
728
5+
4,27
48,
316
14,6
73A
ll 6
5+
55,5
0494
,281
144,
577
65
-74
15,9
1226
,026
41,9
027
5-8
46,
766
12,0
3916
,928
85
+1,
460
3,03
25,
517
All
65
+24
,138
41,0
9764
,347
65
-74
19,1
5831
,453
48,5
307
5-8
49,
394
16,4
4722
,544
85
+2,
814
5,28
49,
156
All
65
+31
,366
53,1
8480
,230
TAB
LE 1
6P
OP
ULA
TIO
N A
T R
ISK
: E
LDER
LY 6
5 Y
EAR
S A
ND
OLD
ER B
Y G
END
ER,
AG
E G
RO
UP
, A
ND
RA
CE/
ETH
NIC
ITY
, A
RIZ
ON
A,
20
00
, 2
01
0,
AN
D 2
01
7
ALL
GR
OU
PS
Tota
l
Mal
e
Fem
ale
WH
ITE
NO
N-H
ISP
AN
IC
Tota
l
Mal
e
Fem
ale
HIS
PA
NIC
Tota
l
Mal
e
Fem
ale
26 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
AG
E G
RO
UP
20
00
20
10
20
17
65
-74
5,89
310
,949
17,8
567
5-8
42,
840
4,89
97,
362
85
+98
81,
474
2,29
7A
ll 6
5+
9,72
117
,322
27,5
156
5-7
42,
773
5,19
68,
563
75
-84
1,14
52,
097
3,31
08
5+
317
455
821
All
65
+4,
235
7,74
812
,694
65
-74
3,12
05,
753
9,29
37
5-8
41,
695
2,80
24,
052
85
+67
11,
019
1,47
6A
ll 6
5+
5,48
69,
574
14,8
216
5-7
48,
537
12,3
7116
,679
75
-84
3,95
95,
790
7,63
78
5+
1,38
81,
851
2,68
2A
ll 6
5+
13,8
8420
,012
26,9
986
5-7
43,
746
5,42
67,
268
75
-84
1,63
72,
358
3,07
48
5+
515
663
981
All
65
+5,
898
8,44
711
,323
65
-74
4,79
16,
945
9,41
17
5-8
42,
322
3,43
24,
563
85
+87
31,
188
1,70
1A
ll 6
5+
7,98
611
,565
15,6
756
5-7
44,
286
9,44
516
,215
75
-84
1,55
84,
129
7,35
68
5+
399
1,03
22,
180
All
65
+6,
243
14,6
0625
,751
65
-74
1,70
03,
943
6,43
47
5-8
463
81,
616
3,10
18
5+
174
363
760
All
65
+2,
512
5,92
210
,295
65
-74
2,58
65,
502
9,78
17
5-8
492
02,
513
4,25
58
5+
225
669
1,42
0A
ll 6
5+
3,73
18,
684
15,4
56
TAB
LE 1
6 (
con
tin
ued
)P
OP
ULA
TIO
N A
T R
ISK
: E
LDER
LY 6
5 Y
EAR
S A
ND
OLD
ER B
Y G
END
ER,
AG
E G
RO
UP
, A
ND
RA
CE/
ETH
NIC
ITY
, A
RIZ
ON
A,
20
00
, 2
01
0,
AN
D 2
01
7
BLA
CK
Tota
l
Mal
e
Fem
ale
AM
ERIC
AN
IN
DIA
NTo
tal
Mal
e
Fem
ale
AS
IAN
Tota
l
Mal
e
Fem
ale
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 27
Mal
eFe
mal
eTo
tal
Mal
eFe
mal
eTo
tal
Mal
eFe
mal
eTo
tal
65
-74
171,
689
192,
152
363,
841
236,
227
261,
665
497,
892
323,
376
363,
885
687,
261
75
-84
101,
550
133,
923
235,
473
127,
730
152,
809
280,
539
165,
009
188,
926
353,
935
85
+23
,028
45,4
9768
,525
37,7
3865
,662
103,
400
54,8
4782
,816
137,
663
Tota
l29
6,26
737
1,57
266
7,83
940
1,69
548
0,13
688
1,83
154
3,23
263
5,62
71,
178,
859
65
-74
1,64
01,
838
3,47
82,
489
2,68
75,
176
2,93
23,
279
6,21
17
5-8
470
892
71,
635
1,03
71,
287
2,32
41,
387
1,71
43,
101
85
+25
237
662
829
447
476
842
560
01,
025
Tota
l2,
600
3,14
15,
741
3,82
04,
448
8,26
84,
744
5,59
310
,337
65
-74
5,06
05,
127
10,1
876,
532
6,75
813
,290
7,64
58,
060
15,7
057
5-8
42,
592
3,07
85,
670
3,42
93,
643
7,07
24,
176
4,44
58,
621
85
+53
297
61,
508
901
1,42
52,
326
1,28
51,
706
2,99
1To
tal
8,18
49,
181
17,3
6510
,862
11,8
2622
,688
13,1
0614
,211
27,3
176
5-7
42,
455
2,56
05,
015
3,65
33,
794
7,44
75,
403
5,54
510
,948
75
-84
1,04
01,
394
2,43
41,
512
1,87
33,
385
2,13
02,
427
4,55
78
5+
239
455
694
369
723
1,09
264
91,
030
1,67
9To
tal
3,73
44,
409
8,14
35,
534
6,39
011
,924
8,18
29,
002
17,1
846
5-7
42,
767
2,98
15,
748
3,61
83,
637
7,25
54,
470
4,53
89,
008
75
-84
1,55
01,
876
3,42
61,
907
2,09
74,
004
2,37
02,
386
4,75
68
5+
360
625
985
416
775
1,19
160
595
81,
563
Tota
l4,
677
5,48
210
,159
5,94
16,
509
12,4
507,
445
7,88
215
,327
65
-74
1,04
01,
151
2,19
11,
148
1,24
02,
388
1,40
01,
454
2,85
47
5-8
457
279
41,
366
661
768
1,42
970
688
61,
592
85
+14
128
742
816
228
244
421
330
952
2To
tal
1,75
32,
232
3,98
51,
971
2,29
04,
261
2,31
92,
649
4,96
86
5-7
423
427
150
526
426
352
739
235
774
97
5-8
413
213
827
016
521
838
318
522
140
68
5+
2549
7434
7210
650
9914
9To
tal
391
458
849
463
553
1,01
662
767
71,
304
65
-74
1,75
71,
511
3,26
82,
199
2,00
64,
205
2,03
42,
082
4,11
67
5-8
478
476
11,
545
1,18
590
82,
093
1,76
41,
458
3,22
28
5+
127
148
275
171
214
385
406
415
821
Tota
l2,
668
2,42
05,
088
3,55
53,
128
6,68
34,
204
3,95
58,
159
65
-74
87,0
6310
1,75
318
8,81
611
8,99
413
6,39
425
5,38
816
7,09
519
2,82
935
9,92
47
5-8
454
,457
75,5
7913
0,03
665
,158
83,0
4114
8,19
981
,848
99,2
2718
1,07
58
5+
12,9
4227
,185
40,1
2720
,884
38,1
7059
,054
29,0
4246
,776
75,8
18To
tal
154,
462
204,
517
358,
979
205,
036
257,
605
462,
641
277,
985
338,
832
616,
817
GR
AH
AM
TAB
LE 1
7P
OP
ULA
TIO
N A
T R
ISK
: E
LDER
LY 6
5 Y
EAR
S A
ND
OLD
ER B
Y G
END
ER,
AG
E G
RO
UP
, A
ND
CO
UN
TY O
F R
ESID
ENC
E,
AR
IZO
NA
, 2
00
0,
20
10
AN
D 2
01
7
AG
E G
RO
UP
20
00
20
10
20
17
AR
IZO
NA
AP
AC
HE
CO
CH
ISE
CO
CO
NIN
O
GIL
A
GR
EEN
LEE
LA P
AZ
MA
RIC
OP
A
28 MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017
Mal
eFe
mal
eTo
tal
Mal
eFe
mal
eTo
tal
Mal
eFe
mal
eTo
tal
65
-74
9,75
19,
316
19,0
6714
,319
13,9
9028
,309
17,4
5217
,532
34,9
847
5-8
44,
881
5,52
610
,407
7,26
17,
170
14,4
319,
732
9,54
319
,275
85
+85
21,
402
2,25
41,
539
2,37
93,
918
2,54
73,
126
5,67
3To
tal
15,4
8416
,244
31,7
2823
,119
23,5
3946
,658
29,7
3130
,201
59,9
326
5-7
42,
954
3,10
96,
063
4,33
24,
535
8,86
75,
534
6,05
111
,585
75
-84
1,27
11,
611
2,88
21,
912
2,22
44,
136
2,63
72,
864
5,50
18
5+
313
500
813
491
747
1,23
870
31,
063
1,76
6To
tal
4,53
85,
220
9,75
86,
735
7,50
614
,241
8,87
49,
978
18,8
526
5-7
428
,873
34,0
4362
,916
38,1
7443
,618
81,7
9251
,866
59,5
1811
1,38
47
5-8
418
,350
25,1
4943
,499
22,1
4127
,465
49,6
0626
,808
31,9
2758
,735
85
+4,
326
8,74
613
,072
7,26
512
,630
19,8
959,
879
15,5
8825
,467
Tota
l51
,549
67,9
3811
9,48
767
,580
83,7
1315
1,29
388
,553
107,
033
195,
586
65
-74
9,00
18,
989
17,9
9016
,421
16,8
3433
,255
25,4
1327
,626
53,0
397
5-8
44,
393
4,78
09,
173
7,49
37,
596
15,0
8912
,860
12,6
6825
,528
85
+80
51,
203
2,00
81,
512
2,21
53,
727
3,13
03,
694
6,82
4To
tal
14,1
9914
,972
29,1
7125
,426
26,6
4552
,071
41,4
0343
,988
85,3
916
5-7
41,
101
1,29
82,
399
1,74
31,
948
3,69
12,
419
2,77
95,
198
75
-84
586
778
1,36
483
11,
046
1,87
71,
196
1,47
92,
675
85
+12
222
935
123
042
665
639
762
01,
017
Tota
l1,
809
2,30
54,
114
2,80
43,
420
6,22
44,
012
4,87
88,
890
65
-74
10,0
6510
,192
20,2
5714
,019
14,9
0628
,925
19,5
5321
,085
40,6
387
5-8
45,
924
7,10
613
,030
7,79
08,
206
15,9
969,
840
10,1
2319
,963
85
+1,
214
2,31
53,
529
2,22
93,
617
5,84
63,
054
4,21
67,
270
Tota
l17
,203
19,6
1336
,816
24,0
3826
,729
50,7
6732
,447
35,4
2467
,871
65
-74
7,92
88,
013
15,9
418,
322
9,05
517
,377
9,76
811
,150
20,9
187
5-8
44,
310
4,42
68,
736
5,24
85,
267
10,5
157,
370
7,55
814
,928
85
+77
81,
001
1,77
91,
241
1,51
32,
754
2,46
22,
616
5,07
8To
tal
13,0
1613
,440
26,4
5614
,811
15,8
3530
,646
19,6
0021
,324
40,9
24
NA
VA
JO
TAB
LE 1
7 (
con
tin
ued
)P
OP
ULA
TIO
N A
T R
ISK
: E
LDER
LY 6
5 Y
EAR
S A
ND
OLD
ER B
Y G
END
ER,
AG
E G
RO
UP
, A
ND
CO
UN
TY O
F R
ESID
ENC
E,
AR
IZO
NA
, 2
00
0,
20
10
AN
D 2
01
7
AG
E G
RO
UP
20
00
20
10
20
17
MO
HA
VE
PIM
A
PIN
AL
SA
NTA
CR
UZ
YA
VA
PA
I
YU
MA
MORTALITY FROM ALZHEIMER'S DISEASE AMONG ARIZONA RESIDENTS, 2000-2017 29
Our Web site at http://pub.azdhs.gov/health-stats provides access to a wide range of statistical information about the health status of Arizonans. The Arizona Health Status and Vital Statistics annual report examines trends in natality, mortality, and morbidity towards established health objectives. Additional reports and studies include Advance Vital Statistics by County of Residence, Injury Mortality among Arizona Residents (accidents, suicides, homicides, legal intervention, firearm-related fatalities, drug-related deaths, drowning deaths, falls among Arizonans 65 years or older), Hospital Inpatient and Emergency Room Statistics (first-listed diagnosis, procedures, mental disorders, asthma, diabetes, influenza and pneumonia, and substance abuse), Community Vital Statistics, Teenage Pregnancy, Differences in Health Status Among Racial/Ethnic Groups, and Health Status Profile of American Indians in Arizona.
ARIZONA DEPARTMENT OF HEALTH SERVICES Bureau of Public Health Statistics
Population Health and Vital Statistics Section
